- Home
- NEO vs NBXG Comparison
NEO vs NBXG Comparison
Compare NEO & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- NBXG
- Stock Information
- Founded
- NEO 2001
- NBXG 2021
- Country
- NEO United States
- NBXG United States
- Employees
- NEO N/A
- NBXG N/A
- Industry
- NEO Precision Instruments
- NBXG Trusts Except Educational Religious and Charitable
- Sector
- NEO Health Care
- NBXG Finance
- Exchange
- NEO Nasdaq
- NBXG Nasdaq
- Market Cap
- NEO 1.0B
- NBXG 1.1B
- IPO Year
- NEO 1999
- NBXG N/A
- Fundamental
- Price
- NEO $8.34
- NBXG $15.13
- Analyst Decision
- NEO Buy
- NBXG
- Analyst Count
- NEO 9
- NBXG 0
- Target Price
- NEO $12.63
- NBXG N/A
- AVG Volume (30 Days)
- NEO 2.7M
- NBXG 243.7K
- Earning Date
- NEO 11-04-2025
- NBXG 01-01-0001
- Dividend Yield
- NEO N/A
- NBXG 10.25%
- EPS Growth
- NEO N/A
- NBXG N/A
- EPS
- NEO N/A
- NBXG N/A
- Revenue
- NEO $689,189,000.00
- NBXG N/A
- Revenue This Year
- NEO $10.40
- NBXG N/A
- Revenue Next Year
- NEO $10.11
- NBXG N/A
- P/E Ratio
- NEO N/A
- NBXG N/A
- Revenue Growth
- NEO 9.70
- NBXG N/A
- 52 Week Low
- NEO $4.72
- NBXG $9.31
- 52 Week High
- NEO $19.12
- NBXG $12.23
- Technical
- Relative Strength Index (RSI)
- NEO 64.46
- NBXG 64.42
- Support Level
- NEO $7.36
- NBXG $14.54
- Resistance Level
- NEO $8.29
- NBXG $14.97
- Average True Range (ATR)
- NEO 0.45
- NBXG 0.19
- MACD
- NEO 0.06
- NBXG 0.03
- Stochastic Oscillator
- NEO 74.47
- NBXG 85.65
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".